http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106880833-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate | 2017-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106880833-B |
| titleOfInvention | Application of antigenic peptides RACGAP1-1 and RACGAP1-2 in preparation of medicines for treating liver cancer |
| abstract | The invention relates to the technical field of medicines, in particular to application of antigenic peptides RACGAP1-1 and RACGAP1-2 in preparation of medicines for preventing and/or treating liver cancer, wherein the amino acid sequences of the antigenic peptides RACGAP1-1 and RACGAP1-2 are respectively shown as SEQ ID No.7 and SEQ ID No. 8. The two antigenic peptides RACGAP1-1 and RACGAP1-2 for treating liver cancer provided by the invention can be used for loading dendritic cells to induce and obtain a large amount of CTL with specific recognition of liver cancer cells, can obviously kill liver cancer solid tumors in vivo, and can be used for preparing medicines for preventing or treating liver cancer. |
| priorityDate | 2017-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 168.